-
Something wrong with this record ?
Whole-Exome Sequencing in Czech Patients with Neurogenetic Diseases
D. Staněk, L. Sedláčková, P. Seeman, D. Šafka Brožková, P. Laššuthová
Language English Country United States
Document type Dataset, Journal Article
- MeSH
- Alleles MeSH
- Databases, Genetic * MeSH
- Adult MeSH
- Phenotype MeSH
- Gene Frequency genetics MeSH
- Genetic Variation genetics MeSH
- Genomics methods MeSH
- Genotype MeSH
- Humans MeSH
- Nervous System Diseases genetics MeSH
- Neurodegenerative Diseases genetics MeSH
- Sequence Analysis, DNA methods MeSH
- Exome Sequencing methods MeSH
- High-Throughput Nucleotide Sequencing methods MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Dataset MeSH
- Geographicals
- Czech Republic MeSH
Aims: Genomic studies play a major role in variant observations between and within populations and in identifying causal relationships between genotypes and phenotypes. Analyses using databases such as gnomAD can provide insight into the frequencies of alleles in large populations. There have been reports that detail such frequencies for several countries and ethnic groups, but as yet, there are no such datasets for the Czech population. Patients and Methods: Whole-exome sequencing (WES) data from 222 individuals from the Czech Republic were analyzed by The Genome Analysis Toolkit best practices pipeline. These data were annotated with the ANNOVAR tool, and the allele frequencies were computed. Results: We developed a database that contains 300,111 variants in 17,512 genes. It is accessible through a simple web query available at prot2hg.com/variantbrowser. Gene-based analyses identified those genes that are most tolerant to variants in our population. Second, allele frequencies in our population were compared to the gnomAD database and groups of variants frequent in our population, but ultra-rare in gnomAD as a whole were identified. Conclusion: This tool should be useful for detecting local variants in the Czech population of patients with neurogenetic diseases.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21012643
- 003
- CZ-PrNML
- 005
- 20210507102320.0
- 007
- ta
- 008
- 210420s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1089/gtmb.2019.0232 $2 doi
- 035 __
- $a (PubMed)32255705
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Staněk, David $u DNA Laboratory, Department of Paediatric Neurology, Charles University and University Hospital Motol, Prague, Czech Republic
- 245 10
- $a Whole-Exome Sequencing in Czech Patients with Neurogenetic Diseases / $c D. Staněk, L. Sedláčková, P. Seeman, D. Šafka Brožková, P. Laššuthová
- 520 9_
- $a Aims: Genomic studies play a major role in variant observations between and within populations and in identifying causal relationships between genotypes and phenotypes. Analyses using databases such as gnomAD can provide insight into the frequencies of alleles in large populations. There have been reports that detail such frequencies for several countries and ethnic groups, but as yet, there are no such datasets for the Czech population. Patients and Methods: Whole-exome sequencing (WES) data from 222 individuals from the Czech Republic were analyzed by The Genome Analysis Toolkit best practices pipeline. These data were annotated with the ANNOVAR tool, and the allele frequencies were computed. Results: We developed a database that contains 300,111 variants in 17,512 genes. It is accessible through a simple web query available at prot2hg.com/variantbrowser. Gene-based analyses identified those genes that are most tolerant to variants in our population. Second, allele frequencies in our population were compared to the gnomAD database and groups of variants frequent in our population, but ultra-rare in gnomAD as a whole were identified. Conclusion: This tool should be useful for detecting local variants in the Czech population of patients with neurogenetic diseases.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a alely $7 D000483
- 650 12
- $a databáze genetické $7 D030541
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a frekvence genu $x genetika $7 D005787
- 650 _2
- $a genetická variace $x genetika $7 D014644
- 650 _2
- $a genomika $x metody $7 D023281
- 650 _2
- $a genotyp $7 D005838
- 650 _2
- $a vysoce účinné nukleotidové sekvenování $x metody $7 D059014
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a nemoci nervového systému $x genetika $7 D009422
- 650 _2
- $a neurodegenerativní nemoci $x genetika $7 D019636
- 650 _2
- $a fenotyp $7 D010641
- 650 _2
- $a sekvenční analýza DNA $x metody $7 D017422
- 650 _2
- $a sekvenování exomu $x metody $7 D000073359
- 651 _2
- $a Česká republika $7 D018153
- 655 _2
- $a dataset $7 D064886
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Sedláčková, Lucie $u DNA Laboratory, Department of Paediatric Neurology, Charles University and University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Seeman, Pavel $u DNA Laboratory, Department of Paediatric Neurology, Charles University and University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Šafka Brožková, Dana $u DNA Laboratory, Department of Paediatric Neurology, Charles University and University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Laššuthová, Petra $u DNA Laboratory, Department of Paediatric Neurology, Charles University and University Hospital Motol, Prague, Czech Republic
- 773 0_
- $w MED00174670 $t Genetic testing and molecular biomarkers $x 1945-0257 $g Roč. 24, č. 5 (2020), s. 264-273
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32255705 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20210507102319 $b ABA008
- 999 __
- $a ok $b bmc $g 1650915 $s 1133022
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 24 $c 5 $d 264-273 $e 20200407 $i 1945-0257 $m Genetic testing and molecular biomarkers $n Genet Test Mol Biomarkers $x MED00174670
- LZP __
- $a Pubmed-20210420